Overview
Visibly offers an FDA-cleared online visual acuity test and telehealth services to renew glasses and contact lens prescriptions from home. The test takes about six minutes on a computer or mobile device, with results reviewed by a licensed doctor in the user’s state and a new prescription issued within 24 hours. It serves both consumers (B2C) and eye care professionals/optical retailers (B2B) via a white-label platform that providers can integrate into their own workflows to broaden access and boost eyewear sales. Revenue comes from test fees, prescription fulfillment, and verification services, shared with partners, and the company aims to improve access to at-home eye care and help providers grow their service offerings and eyewear revenue, aided by acquisitions like Lensabl and EyecareLive.
Work here?Claim your company
Simplify's take
What believers are saying
- Easee acquisition on September 2, 2025 expands Visibly into certified European digital eyecare.
- Lensabl adds optical e-commerce, letting Visibly monetize eyewear sales beyond test fees.
- EyecareLive video consults deepen provider workflows and increase retention across online eye care.
What critics are saying
- FDA clearance stays limited to adults 22-40 renewing prescriptions, capping total addressable market.
- State licensure and prescribing rules can block doctor review, delaying prescriptions within 24 hours.
- If FDA or state boards tighten remote-eye-exam rules, Visibly’s core model breaks.
What makes Visibly unique
- First FDA-cleared at-home visual acuity test anchors Visibly’s regulatory moat.
- Lensabl, EyecareLive, and Easee combine testing, telehealth, retail, and European reach.
- Visibly Verification automates contact-lens prescription compliance for retailers and providers.
Help us improve and share your feedback! Did you find this helpful?